Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Post-therapy damage in medulloblastoma patients can be mistaken for new tumors

17.11.2004


St. Jude scientists find that radiation and high-dose chemotherapy damage is usually transient but can mimic cancer and prompt needless additional treatment



Irradiation and high-dose chemotherapy used to treat two types of brain tumors--medulloblastoma and supratentorial PNET--can cause changes in the brain’s white matter that look like tumors when seen on MRI scans. This finding, by a team of investigators led by St. Jude Children’s Research Hospital, is published in the Nov. 15 issue of Journal of Clinical Oncology (JCO). White matter is the part of the brain composed of nerves that are covered in a pearly-white sheath. Much of the cerebral cortex, where high level thinking occurs, is made of white matter.

The study demonstrates that this damage, called white matter lesions (WMLs), can be mistaken for recurrent cancer, prompting physicians to treat the patient aggressively--and needlessly--with more radiation and chemotherapy. "Irradiation and high-dose chemotherapy are treatments we want to use as sparingly as possible," said Amar Gajjar, M.D., member of Hematology-Oncology and director of Neuro-oncology at St. Jude. "This new information represents an important caution sign for physicians who otherwise might assume that WMLs are actually tumors that need further treatment."


Gajjar is senior author of the JCO report, which is the first to describe both the finding and the actual incidence of early-onset WMLs--that is, how frequently these lesions occur in patients with medulloblastoma or PNET who have been treated with radiation and high-dose chemotherapy following surgery. The study is also the first to note the impact of such changes in white matter on intellectual outcome in children with brain tumors. Specifically, the study found that the presence of WMLs is associated with a decline in neurocognitive, or intellectual, function. "In the vast majority of children, the changes seen on MRI scans after treatment are WMLs and not cancer," says Maryam Fouladi, M.D., assistant member of St. Jude Hematology-Oncology and lead author of the report. "Physicians can follow up these initial findings with repeat MRI scans to determine whether the WMLs disappear. If they do disappear, then it wasn’t cancer and didn’t require treatment. But even though these changes tend to be only temporary, some children with these changes tends to develop permanent neurologic problems, such as difficulty swallowing."

The team followed 127 patients for up to 13 months after the start of treatment for brain cancer. During this time 22 of these patients developed WMLs following treatment for brain cancer. The WMLs disappeared in 16 patients (73 percent) within 23.5 months after being detected. In two patients the WMLs remained after 19 and 31 months, respectively. Two other patients developed cancer again while still showing evidence of WMLs. In the remaining patients the WML led to tissue breakdown. Patients with WMLs experienced a significant decline in estimated IQ and math scores.

The researchers concluded that, in patients with medulloblastoma or PNET who had been treated with irradiation and high-dose radiation, WMLs are usually short-lived and do not cause symptoms. However, these WMLs can mimic the early stages of tumor recurrence, and thus make it difficult for physicians to accurately diagnose the return of cancer.

Other authors of this report are Fred Laningham, James W. Langston, Larry E. Kun and Raymond K. Mulhern (St. Jude); Murali Chintagumpala, Charles W. McCluggage, Shaio Woo and Kevin Krull (Texas Children’s Hospital/Baylor College of Medicine, Houston); David Ashley (Royal Children’s Hospital, Melbourne, Australia); and Stewart J. Kellie (Children’s Hospital at Westmead, Sydney, Australia).

Bonnie Cameron | EurekAlert!
Further information:
http://www.stjude.org

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>